BELL & LINDSAY, INC.

Lobbying for METABOLIC SYNDROME INSULIN INFUSION HOLDINGS LLC · treatment of metabolic disorders, including diabetes.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $15,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Health Issues

education around MSII's value proposition to treat metabolic health disorders.

Accounting

education around MSII's value proposition to treat metabolic health disorders.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.